Trials / Unknown
UnknownNCT00982605
EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)
EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Heidelberg University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-TBNA).
Detailed description
NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | EBUS_TBNA | EBUS during bronchoscopy |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-10-01
- Completion
- 2011-01-01
- First posted
- 2009-09-23
- Last updated
- 2009-10-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00982605. Inclusion in this directory is not an endorsement.